This is a Validated Antibody Database (VAD) review about human CAB39, based on 3 published articles (read how Labome selects the articles), using CAB39 antibody in all methods. It is aimed to help Labome visitors find the most suited CAB39 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CAB39 synonym: CGI-66; MO25

Abcam
domestic rabbit monoclonal (EP1680Y)
  • western blot; human; loading ...; fig 4d
Abcam CAB39 antibody (Abcam, ab51132) was used in western blot on human samples (fig 4d). Theranostics (2018) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (C49D8)
  • western blot; human; 1:1000; loading ...; fig s3a
Cell Signaling Technology CAB39 antibody (CST, 2716s) was used in western blot on human samples at 1:1000 (fig s3a). J Exp Med (2020) ncbi
domestic rabbit monoclonal (C49D8)
  • western blot; human; loading ...; fig 4h
Cell Signaling Technology CAB39 antibody (Cell Signaling Technology, 2716S) was used in western blot on human samples (fig 4h). Mol Cell (2019) ncbi
Articles Reviewed
  1. Hermanova I, Z iga Garc a P, Caro Maldonado A, Fernandez Ruiz S, Salvador F, Mart n Mart n N, et al. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer. J Exp Med. 2020;217: pubmed publisher
  2. Gao X, Zhao L, Liu S, Li Y, Xia S, Chen D, et al. γ-6-Phosphogluconolactone, a Byproduct of the Oxidative Pentose Phosphate Pathway, Contributes to AMPK Activation through Inhibition of PP2A. Mol Cell. 2019;76:857-871.e9 pubmed publisher
  3. Zeng J, Liu W, Fan Y, He D, Li L. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy. Theranostics. 2018;8:109-123 pubmed publisher